Rhinocerebral mucormycosis treated with 32 gram liposomal amphotericin B and incomplete surgery: a case report.

Cagatay, A A; Oncü, S S; Calangu, S S; Yildirmak, T T; Ozsüt, H H; Eraksoy, H H

Cagatay, A A; Oncü, S S; Calangu, S S; Yildirmak, T T; Ozsüt, H H; Eraksoy, H H.

Affiliation

Cagatay AA; Department of Clinical Bacteriology and Infectious Diseases, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey. atayon@yahoo.com

BMC Infect Dis ; 1: 22, 2001.

Article in En | MEDLINE | ID: mdl-11737868

Subject(s)

Amphotericin B/therapeutic use; Antifungal Agents/therapeutic use; Mucormycosis/drug therapy; Adult; Amphotericin B/administration & dosage; Antifungal Agents/administration & dosage; Diabetes Complications; Drug Carriers; Humans; Liposomes; Male; Mucormycosis/etiology; Treatment Outcome

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Amphotericin B / Mucormycosis / Antifungal Agents Type of study: Etiology_studies Limits: Adult / Humans / Male Language: En Journal: BMC Infect Dis Journal subject: DOENCAS TRANSMISSIVEIS Year: 2001 Document type: Article Affiliation country: Turkey Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google